Epidemic MRSA clone ST22-IV is more resistant to multiple host-and environment-related stresses compared with ST228-I

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 3, 2015, Pages 757-765

  Baldan, Rossella ^a   Rancoita, Paola Maria Vittoria ^b   Di Serio, Clelia ^b   Mazzotti, Maria ^a   Cichero, Paola ^a   Ossi, Cristina ^a   Biancardi, Anna ^a   Nizzero, Paola ^a   Saracco, Alberto ^a   Scarpellini, Paolo ^a   Cirillo, Daniela Maria ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Fitness; S. aureus; Stress resistance

Indexed keywords

ALPHA HEMOLYSIN; ANTIBIOTIC AGENT; BETA HEMOLYSIN; HEMOLYSIN; UNCLASSIFIED DRUG; ACID; ALKALI; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHEMICAL STRESS; CLONE; DESICCATION; ENVIRONMENTAL STRESS; HEAT SHOCK; HEAT TOLERANCE; HEMOLYSIS; HOST; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; OSMOLARITY; OSMOTIC STRESS; OXIDATIVE STRESS; PATHOGENICITY; PHENOTYPE; PHYSICAL STRESS; PNEUMONIA; SURVIVAL; BACTERIOLYSIS; COMPARATIVE STUDY; DRUG EFFECTS; EUROPE; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; OSMOTIC PRESSURE; PHYSIOLOGICAL STRESS; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS;

ACIDS; ALKALIES; BACTERIOLYSIS; EUROPE; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSMOTIC PRESSURE; OXIDATIVE STRESS; STAPHYLOCOCCAL INFECTIONS; STRESS, PHYSIOLOGICAL; VIRULENCE FACTORS;

EID: 84928171146     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku467     Document Type: Article

References (41)

1. Stefani S, Chung DR, Lindsay JA et al. Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 2012; 39:273-82.
2. ECDC. Antimicrobial Resistance Surveillance in Europe 2012. http://www. ecdc.europa.eu/en/publications/Publications/antimicrobial-resistancesurveillance-europe-2012.pdf.
3. Monecke S, Coombs G, Shore AC et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 2011; 6: e17936.
4. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629-41.
5. Mediavilla JR, Chen L, Mathema B et al. Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr Opin Microbiol 2012; 15:588-95.
6. Lindsay JA. Hospital-associated MRSA and antibiotic resistance-what have we learned from genomics? Int J Med Microbiol 2013; 303:318-23.
7. Strommenger B, Bartels MD, Kurt K et al. Evolution ofmethicillin-resistant Staphylococcus aureus towards increasing resistance. J Antimicrob Chemother 2014; 69:616-22.
8. McAdam PR, Templeton KE, Edwards GF et al. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2012; 109:9107-12.
9. Ali H, Nash JQ, Kearns AM et al. Outbreak of a South West Pacific clone Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus infection in a UK neonatal intensive care unit. J Hosp Infect 2012; 80:293-8.
10. Carpaij N, Willems RJ, Rice TW et al. Genetic variation in spatiotemporal confined USA300 community-associated MRSA isolates: a shift from clonal dispersion to genetic evolution? PLoS One 2011; 6: e16419.
11. Moore CL, Hingwe A, Donabedian SM et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community-and healthcareassociated infections. Int J Antimicrob Agents 2009; 34:148-55.
12. Knight GM, Budd EL, Whitney L et al. Shift in dominant hospitalassociated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time. J Antimicrob Chemother 2012; 67:2514-22.
13. Holden MT, Hsu LY, Kurt K et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res 2013; 23:653-64.
14. Richardson JF, Reith S. Characterization of a strain of methicillinresistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J Hosp Infect 1993; 25:45-52.
15. Conceiçao T, Aires-de-Sousa M, FuziMet al. Replacement of methicillinresistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clin Microbiol Infect 2007; 13:971-9.
16. Aires-de-Sousa M, Correia B, de Lencastre H et al. Changing patterns in frequency of recovery of five methicillin-resistant Staphylococcus aureus clones in Portuguese hospitals: surveillance over a 16-year period. J Clin Microbiol 2008; 46:2912-17.
17. Conceição T, Diamantino F, Coelho C et al. Contamination of public buses with MRSA in Lisbon, Portugal: a possible transmission route of major MRSA clones within the community. PLoS One 2013; 8: e77812.
18. Espadinha D, Faria NA, Miragaia M et al. Extensive dissemination of methicillin-resistant Staphylococcus aureus (MRSA) between the hospital and the community in a country with a high prevalence of nosocomial MRSA. PLoS One 2013; 8: e59960.
19. Mollaghan AM, Lucey B, Coffey A et al. Emergence of MRSA clone ST22 in healthy young adults in the community in the absence of risk factors. Epidemiol Infect 2010; 138:673-6.
20. Dhawan B, Rao C, Udo EE, Gadepalli R et al. Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type Vepidemic clones in a tertiary hospital: challenge to infection control. Epidemiol Infect 2014; 2:1-11.
21. Baldan R, Testa F, Lore` NI et al. Factors contributing to epidemic MRSA clones replacement in a hospital setting. PLoS One 2012; 7: e43153.
22. Baldan R, Cavallerio P, Parlato C et al. Meticillin-resistant Staphylococcus aureus SCCmec type IV: nosocomial transmission and colonization of healthcare workers in a neonatal intensive care unit. J Hosp Infect 2008; 69:304-6.
23. Baldan R, Tassan Din C, Semeraro G et al. Severe community-onset infections in healthy individuals caused by community-acquired MRSA in an Italian teaching hospital. J Hosp Infect 2009; 72:271-3.
24. Cadilla A, David MZ, Daum RS et al. Association of high-level mupirocin resistance and multidrug-resistant methicillin-resistant Staphylococcus aureus at an academic center in the midwestern United States. J Clin Microbiol 2011; 49:95-100.
25. Sakoulas G, Eliopoulos GM, Moellering RC et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2002; 46:1492-502.
26. Shaw LN, Lindholm C, Prajsnar TK et al. Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One 2008; 3: e3844.
27. Singh VK, Utaida S, Jackson LS et al. Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology 2007; 153:3162-73.
28. Pamp SJ, Frees D, Engelmann S et al. Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus. J Bacteriol 2006; 188:4861-70.
29. Rountree PM. The effect of desiccation on the viability of Staphylococcus aureus. J Hyg 1963; 61:265-72.
30. Thouverez M, Muller A, Hocquet D et al. Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital. J Med Microbiol 2003; 52:801-6.
31. Bubeck Wardenburg J, Bae T, Otto M et al. Poring over pores: a-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-6.
32. Salgado-Pabón W, Herrera A, Vu BG et al. Staphylococcus aureus b-toxin production is common in strains with the b-toxin gene inactivated by bacteriophage. J Infect Dis 2014; 210:784-92.
33. Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol 2014; 17:32-7.
34. Clements MO, Foster SJ. Stress resistance in Staphylococcus aureus. Trends Microbiol 1999; 7:458-62.
35. Gatlin CL, Pieper R, Huang ST et al. Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 2006; 6:1530-49.
36. Gründling A, Schneewind O. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol 2006; 188:2463-72.
37. Tsai M, Ohniwa RL, Kato Y et al. Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity. BMC Microbiol 2011; 11:13.
38. Scott WJ. Water relations of Staphylococcus aureus at 308C. Aust J Biol Sci 1953; 6:549-64.
39. Vijaranakul U, Nadakavukaren MJ, de Jonge BL et al. Increased cell size and shortened peptidoglycan interpeptide bridge of NaCl-stressed Staphylococcus aureus and their reversal by glycine betaine. J Bacteriol 1995; 177:5116-21.
40. Hart J, Christiansen HJ, Lee R et al. Increased EMRSA-15 health-care worker colonization demonstrated in retrospective review of EMRSA hospital outbreaks. Antimicrob Resist Infect Control 2014; 3:7.
41. Cebrián G, Sagarzazu N, Pagán R et al. Development of stress resistance in Staphylococcus aureus after exposure to sublethal environmental conditions. Int J Food Microbiol 2010; 140:26-33.